Computational studies of new 1,4-dihydropyridines containing 4-(5)-chloro-2-ethyl-5-(4)-imidazolyl substituent: QSAR and docking

被引:22
作者
Davood, Asghar [1 ]
Nematollahi, Alireza [1 ]
Iman, Maryam [2 ]
Shafiee, Abbas [3 ]
机构
[1] Islamic Azad Univ, Fac Pharm, Dept Med Chem, Tehran, Iran
[2] Mashad Univ Med Sci, Fac Pharm, Dept Pharmaceut Sci, Mashhad, Iran
[3] Univ Tehran Med Sci, Fac Pharm, Dept Med Chem, Tehran, Iran
关键词
1,4-Dihydropyridine; CCBs; Molecular modeling; Docking; QSAR; Imidazole; CHANNEL ANTAGONIST ACTIVITY; CALCIUM-CHANNEL; DRUG DESIGN; 3D QSAR; CONFORMATION;
D O I
10.1007/s00044-009-9171-2
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
1,4-Dihydropyridine has been recognized as calcium channel blocker agents. In this research we did computational studies of some newly synthesized dihydropyridine containing 4-[4-(5)-chloro-2-ethyl-5-(4)-imidazolyl] moiety. DHPs were built by the HYPERCHEM program and conformational studies were performed through semi-empirical method followed by PM3 method. QSAR descriptors were obtained from E-DRAGON. QSAR equations were obtained from multilinear regression method. This simple equation can be used to estimate the CCBs activity for new compounds of this series of compounds. The sum of the energy of the highest occupied molecular orbital (HOMO), molecular volume (MV), the GETAWAY, and the WHIM were identified as the most significant descriptors. Docking study was performed by using AutoDock4 program on the all compounds which have already been reported by Davood et al. The obtained results show that experimental PIC50 agree with docking results for potent compounds (10a, 6b). These computational studies can offer some useful references for understanding the action mechanism and performing the molecular design or modification of this series of CCB agents.
引用
收藏
页码:58 / 70
页数:13
相关论文
共 29 条
  • [21] Hansch C, 1995, EXPLORING QSAR FUNDA, P551
  • [22] HUEY R, 2007, USING AUTODOCK 4 AUT
  • [23] NEW DEVELOPMENTS IN CA-2+ CHANNEL ANTAGONISTS
    JANIS, RA
    TRIGGLE, DJ
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1983, 26 (06) : 775 - 785
  • [24] QSAR and 3D QSAR in drug design .1. methodology
    Kubinyi, H
    [J]. DRUG DISCOVERY TODAY, 1997, 2 (11) : 457 - 467
  • [25] QSAR and 3D QSAR in drug design .2. Applications and problems
    Kubinyi, H
    [J]. DRUG DISCOVERY TODAY, 1997, 2 (12) : 538 - 546
  • [26] Structural study of 3,4-dihydropyridones and furo[3,4-b]-2(1H)-pyridones as potential calcium channel modulators.
    Ochoa, E
    Suárez, M
    Verdecia, Y
    Pita, B
    Martín, N
    Quinteiro, M
    Seoane, C
    Soto, JL
    Duque, J
    Pomés, R
    [J]. TETRAHEDRON, 1998, 54 (40) : 12409 - 12420
  • [27] Ramesh M, 1987, Drug Des Deliv, V2, P79
  • [28] STUDIES DIRECTED TOWARD ASCERTAINING THE ACTIVE CONFORMATION OF 1,4-DIHYDROPYRIDINE CALCIUM ENTRY BLOCKERS
    ROVNYAK, G
    ANDERSEN, N
    GOUGOUTAS, J
    HEDBERG, A
    KIMBALL, SD
    MALLEY, M
    MORELAND, S
    PORUBCAN, M
    PUDZIANOWSKI, A
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1988, 31 (05) : 936 - 944
  • [29] Shafiee A, 1998, Pharm Acta Helv, V73, P75, DOI 10.1016/S0031-6865(98)00004-1